🔗 Share this article

A shadow market for unapproved slimming medications is being driven by social media fitness personalities and sellers on messaging platforms, according to new investigations.

Investigational Treatment Gaining Traction Online

Retatrutide, which remains in research studies, is being promoted by online personalities for its supposed fat-burning effects. Followers are encouraged to message these profiles privately for supplier links, while also obtaining discount codes.

Active Commerce on Messaging Platforms

Additionally, a robust trade exists on Telegram, where groups with thousands of members share comparison images, injection guides and assertions of rapid British shipping. Vendors market the drug there before directing buyers to other platforms for transactions.

Learning About The Experimental Drug

Retatrutide is an investigational injectable developed by US drugmaker Eli Lilly. The treatment targets three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials suggest it could assist individuals lose up to 25% of their total weight. Referred to as the “triple G”, the drug is being hailed online as the next Ozempic.

Medical Experts Voice Concerns

Nevertheless, doctors and chemists have cautions that the sale of what is still an unapproved drug in the UK is a cause for concern and could result in users injecting products of unknown origin.

Several experts said the popularity for the experimental drug could be linked to the rising cost of licensed weight loss products such as Mounjaro.

Legal Position and Implementation

Selling the unapproved drug on TikTok or messaging apps is prohibited in the United Kingdom, as it is an unlicensed drug that cannot be promoted or supplied for human use under the Human Medicines Regulations 2012.

Some influencers try to sidestep the regulations by calling to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled drug, but promotion and supply can still violate medicines, marketing, and customer regulations, potentially leading to penalties, legal action or prison.

Service Reaction and Material Elimination

Based on TikTok, the service has removed problematic material and banned associated hashtags and search suggestions. The organization said it was dedicated to keeping the platform safe and investing in strengthening enforcement strategies.

Digital Trading Activities

Research also discovered communities with up to nine thousand participants selling retatrutide using Telegram's built-in search feature, which functions like a online catalog. Typing “retatrutide” immediately brings up channels with thousands of users, filled with images of weight loss, glowing testimonials and step-by-step guides for mixing or administering at home.

Within minutes of joining one community, a seller shared WhatsApp details, where most transactions take place. The seller sent an instruction manual and guaranteed shipping within 48 hours. When questioned whether the product was genuine, one vendor responded: “You can’t be sure.” Another provided a image of a supposed testing documentation. Not one inquired about weight, health issues or previous experience.

Item Details and Pricing

Inside these groups, messages show dark colored parcels with postal service labels, stating to include new batches. One communication stated: “It took eight of us to load them this morning.”

Customers can select between dry substance containers, prepared at home with purified liquid, or pre-filled pens typically priced at 160 pounds for 20 milligrams. When asked how much time a injector should last, vendors give contradictory responses varying between a few weeks to “depends on your body”.

Service Moderation and Security Actions

A spokesperson for the messaging service stated it actively moderated dangerous material on its platform including content that promoted the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.

Medical Professional Warnings

“Individuals are injecting materials they can’t verify. Even if the research behind this drug is valid, these online products may not contain what they claim,” stated a pharmacy expert, the director of pharmacy at Chemist4U.

Dr Crystal Wyllie of an online medical service linked the increase in interest to recent cost increases for approved weight-loss medications such as Mounjaro. “With costs increasing, individuals are using social media. But counterfeit treatments are extremely dangerous. You cannot know what’s contained or whether the conditions they were made in was sterile,” she explained.

Her team has already seen individuals injured by personal administration from unconfirmed sources. “We recognize the frustration, but buying from Telegram or WhatsApp is taking chances with your health,” said Wyllie. “These substances could be contaminated or improperly measured.”

Manufacturer Statement

A representative from the pharmaceutical company said the substance was in third stage research studies and had not been reviewed or approved by any government authority anywhere in the world. “Consequently at this point no one can sell [it] for personal consumption,” they explained, noting that any product “falsely representing itself as a company experimental substance not yet authorized … may subject users to possibly serious health risks”.